Research & Manuscripts

You can find the full list of my publications on Google Scholar

Select publications

Date	Article | Authors	Journal
8/2022	Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients Ceyhan-Birsoy O, Jayakumaran G, Kemel Y, …, Zehir A, and Mandelker D	Genome Med.
10/2022	Enhanced clinical assessment of hematologic malignancies through routine paired tumor:normal sequencing Ptashkin RN, Ewalt MD, Jayakumaran G, …, Zehir A, and Arcila ME	Biorxiv
6/2021	Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS Rose Brannon A, Jayakumaran G, Diosdado M, …, Zehir A, and Benayed R	Nat. Commun.
2/2021	Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors Fiala EM, Jayakumaran G, Mauguen A, …, Zehir A, and Walsh MF	Nature Cancer
10/2021	Clonal hematopoiesis is associated with risk of severe Covid-19 Bolton KL, Koh Y, Foote MB, …, Kim NJ, and Zehir A	Nat. Commun.
9/2020	MiMSI - a deep multiple instance learning framework improves microsatellite instability detection from tumor next-generation sequencing Ziegler J, Hechtman JF, Ptashkin R, …, Fuchs TJ, and Zehir A	Biorxiv
11/2020	Cancer therapy shapes the fitness landscape of clonal hematopoiesis Bolton KL, Ptashkin RN, Gao T, …, Zehir A, and Papaemmanuil E	Nat. Genet.
11/2018	Prevalence of Clonal Hematopoiesis Mutations in Tumor-Only Clinical Genomic Profiling of Solid Tumors Ptashkin RN, Mandelker DL, Coombs CC, …, Berger MF, and Zehir A	Jama Oncol
9/2017	Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes Coombs CC, Zehir A, Devlin SM, …, Levine RL, and Berger MF	Cell Stem Cell
6/2017	Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients Zehir A, Benayed R, Shah RH, …, Ladanyi M, and Berger MF	Nat. Med.
10/2017	Reliable Pan-Cancer Microsatellite Instability Assessment by Using Targeted Next-Generation Sequencing Data Middha S, Zhang L, Nafa K, …, Zehir A, and Hechtman JF	Jco Precis Oncol
5/2015	Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology Cheng DT, Mitchell TN, Zehir A, …, Ladanyi M, and Berger MF	J. Mol. Diagn.